Results 101 to 110 of about 31,423 (257)

Risk of Hypocalcemia and the Need to Augment Calcium Supplementation After Total Thyroidectomy

, 2020
Harish Verma, Pattatheyil Arun, Rajeev Sharan, Kapila Manikantan, Prateek Jain   +4 more
openalex   +2 more sources

Identification and Functional Characterization of a Novel Mutation in the Human Calcium-Sensing Receptor That Co-Segregates With Autosomal-Dominant Hypocalcemia [PDF]

, 2018
Anne Qvist Rasmussen, Niklas Rye Jørgensen, Peter Schwarz   +2 more
openalex   +1 more source

Guidelines for the Diagnosis and Treatment of Advanced Breast Cancer in China (2024 Edition)

Cancer Innovation, Volume 4, Issue 6, December 2025.
“The core objective of this guideline is to personalize the management of advanced breast cancer through molecular subtyping, optimizing the balance between survival and quality of life. We integrate recent evidence‐based advances and underscore the essential roles of multidisciplinary collaboration and management of patient‐reported outcomes (PROs ...
Breast Cancer Expert Committee of the National Quality Control Center for Cancer, Breast Cancer Expert Committee of the China Anti‐Cancer Association, Cancer Drug Clinical Research Committee of the China Anti‐Cancer Association   +2 more
wiley   +1 more source

Lower Rates of Hypocalcemia Following Near-Infrared Autofluorescence Use in Thyroidectomy: A Meta-Analysis of RCTs

Diagnostics
Background: Iatrogenic injury of the parathyroid glands is the most frequent complication after total thyroidectomy. Objective: To determine the effectiveness of near-infrared autofluorescence (NIRAF) in reducing postoperative hypocalcemia following ...
Karthik N. Rao, Renu Rajguru, Prajwal Dange, Diana Vetter, Frederic Triponez, Iain J. Nixon, Gregory W. Randolph, Antti A. Mäkitie, Mark Zafereo, Alfio Ferlito   +9 more
doaj   +1 more source

A Phase II Pilot Study of Anti‐PD‐L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple‐Negative Breast Cancer With or Without Germline BRCA Mutation

Cancer Medicine, Volume 14, Issue 23, December 2025.
ABSTRACT Background Immunostimulatory effects of PARP inhibitors could increase sensitivity to immune checkpoint inhibitors. The previous Phase II trial (MEDIOLA) reported clinical benefits of durvalumab and olaparib (D + O) in patients with germline BRCA‐mutated (gBRCAm) HER2‐negative metastatic breast cancer.
Takeo Fujii, Ashley Cimino‐Mathews, Stanley Lipkowitz, Min‐Jung Lee, Jayakumar Nair, Britanny Brooke Solarz, Alexandra Zimmer, Bernadette Redd, Elliot B. Levy, Shraddha Rastogi, Nahoko Sato, Ann McCoy, Seth M. Steinberg, Jung‐Min Lee   +13 more
wiley   +1 more source

A Phase 1 Trial of Fimepinostat in Children and Adolescents With Relapsed and Refractory Solid and CNS Tumors

Cancer Medicine, Volume 14, Issue 23, December 2025.
ABSTRACT Background Fimepinostat, an oral dual inhibitor of histone deacetylase (HDAC) and phosphatidylinositol‐4,5‐bisphosphate 3‐kinase (PI3K), has shown activity in preclinical models of Myc‐driven pediatric malignancies. This Phase 1 trial aimed to determine the recommended pediatric Phase 2 dose (RPP2D), describe the toxicity profile, and evaluate
David S. Shulman, Kieuhoa T. Vo, Frank M. Balis, Holly Lindsay, Rochelle Bagatell, Andrew E. Place, Susan N. Chi, Suzanne Shusterman, Suzanne Ezrre, Jeffrey Czaplinski, Ketki Bhushan, Pei‐Chi Kao, Wendy B. London, Steven G. DuBois   +13 more
wiley   +1 more source

Hypocalcemia After Thyroidectomy in Patients Taking Proton Pump Inhibitors

Laryngoscope Investigative Otolaryngology
Objective Calcium homeostasis is regulated by the effects of parathyroid hormone (PTH) and vitamin D on the bones, GI tract, and kidneys. Post‐thyroidectomy hypoparathyroidism and resultant hypocalcemia are common complications associated with prolonged ...
Maxwell Rossip, F. Jeffrey Lorenz, Neerav Goyal, David Goldenberg   +3 more
doaj   +1 more source

Recurrent Nephrolithiasis and Beyond: The Long Diagnostic Odyssey of a Case of CLDN16 Mutation

Clinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis (FHHNC) is a rare tubulopathy resulting from mutations in the CLDN16 and CLDN19 genes. The affected individuals commonly present with polyuria, polydipsia, excessive urinary magnesium (Mg) and calcium (Ca) wasting, nephrocalcinosis, nephrolithiasis, recurrent urinary tract ...
Abdullah Al Noman Bhuiyan, Nazia Akter, Tahniyah Haq, Md. Fariduddin, Shahjada Selim   +4 more
wiley   +1 more source

Denosumab-induced hypocalcemia post bariatric surgery—a severe and protracted course: a case report [PDF]

, 2023
Mohd Hazriq Awang, Sharifah Faradila Wan Muhamad Hatta, Aimi Fadilah Mohamad, Rohana Abdul Ghani   +3 more
openalex   +1 more source

Mpox With Digestive Manifestations in a 16‐Year‐Old Adolescent Girl: A Case Report

Clinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Mpox, primarily known for cutaneous and mucosal manifestations, can present atypically. This case reports a rare digestive form with peritonitis in a 16‐year‐old girl. A febrile adolescent presented with acute abdominal pain, peritonitis, systemic inflammation, anemia, and ionic disturbances.
Criss Koba Mjumbe, James Mushamalirwa Bafurume, Edouard Mbaya Munianji, Christian Tague, Aymar Akilimali   +4 more
wiley   +1 more source